William Blair News

Keep up to date on our recent transactions, announcements, and events.

A hand holding a smartphone in front of a laptop

News and Events

Equity Research

Alto Neuroscience, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Alto Neuroscience, Inc. (ANRO $13.72), a company focused on developing novel therapies for high-unmet-need indications in psychiatry supported by AI-enabled precision approaches to identify response biomarkers.

Read more

Equity Research

Keros Therapeutics, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Keros Therapeutics, Inc. (KROS $59.49), a company focused on the development of novel therapies targeting the TGF-β superfamily of cytokines, which play essential roles in the proliferation and differentiation of numerous cell types.

Read more

Awards and Recognition

In The Media

Equity Research

Lewis Jones Quoted in Bloomberg

William Blair Investment Management portfolio manager Lewis Jones was quoted in Bloomberg’s coverage of a major sell-off of Colombian bonds.

Read more

Private Wealth Management

Tom Wilson Featured in Barron's

William Blair private wealth management financial advisor Tom Wilson shared the story of his more than three decades at the firm in a feature in Barron’s.

Read more

Contact Us

Please contact Tony Zimmer with any media-related inquiries or to request a complete media kit.

+1 312 364 8611
tzimmer@williamblair.com

Tony Zimmer

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures